Zang, Chuanbing <br/><br/>
Targeting multiple tyrosine kinase receptors with Dovitinib blocks invasion and the interaction between tumor cells and cancer-associated fibroblasts in breast cancer.  [electronic resource] 

 -  Cell cycle (Georgetown, Tex.)  2015 
 - 1291-9 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1551-4005 
<br/><br/><label>Standard No.: </label>10.4161/15384101.2014.995050  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Benzimidazoles--pharmacology<br/>Breast Neoplasms--metabolism<br/>Cell Line, Tumor<br/>Cell Movement--drug effects<br/>Chemokine CCL2--analysis<br/>Chemokine CCL5--analysis<br/>Coculture Techniques<br/>Culture Media, Conditioned--pharmacology<br/>Female<br/>Fibroblasts--cytology<br/>Humans<br/>MCF-7 Cells<br/>Phosphatidylinositol 3-Kinases--metabolism<br/>Phosphoinositide-3 Kinase Inhibitors<br/>Phosphorylation--drug effects<br/>Protein Kinase Inhibitors--pharmacology<br/>Proto-Oncogene Proteins c-akt--metabolism<br/>Quinolones--pharmacology<br/>Receptor Protein-Tyrosine Kinases--antagonists & inhibitors<br/>Signal Transduction--drug effects<br/>TOR Serine-Threonine Kinases--metabolism<br/>Vascular Endothelial Growth Factor A--metabolism